Medical Research Compass · Mar 25 Daily Digest
Cancer Therapy Breakthroughs
- 🔥 UTSW-InterAct Gene Therapy Licensing: UTSW Southwestern Medical Center and InterAct Therapeutics announced an...

Created by Bethan Herrman
Peer‑reviewed clinical trials, breakthrough treatments, public‑health guidance, and lifestyle prevention for cancer, heart, brain health
Explore the latest content tracked by Medical Research Compass
Unconventional breakthrough in scalable cancer immunotherapy:
Key developments in GLP-1 weight loss therapies:
MASLD epidemic: Affects 30% globally, long lacking targeted therapies.
The brutal fight over Obamacare ignited a culture war that eroded public trust in science, fueling pandemic skepticism.
Key shifts:
Tau PET imaging uncovers associations between tau pathology and clinical symptoms in pre-manifest and early Huntington's disease (HD).
Key...
Dr. Tanmay Kulkarni highlights TAVI as a game-changing, minimally invasive valve implant avoiding open-heart surgery.
Key trend in patient education on precision diagnostics:
Key trend in CAR-T expansion for hematologic malignancies:
FDA priority review accepted for zilganersen NDA, with PDUFA target Sept 22, 2026—accelerating first potential therapy for AxD.
Two visions inspire stronger public health protections:
Key trends from recent meetings signal fast-evolving targeted therapies:
Cumulative exposures layer over a lifetime to shape health outcomes, not just present conditions.
Key models:
Key advances in AI for neurodegenerative diagnostics:
Challenging the 10,000 steps myth—new evidence shows fewer steps deliver major benefits:
Access innovative cancer treatments via clinical trials – research studies testing new therapies. A concise 2:21 video outlines benefits of participation; dive deeper at cancer.org/clinicaltrials.